Stocktoria
Krystal Biotech, Inc. KRYS
Krystal Biotech, Inc. statistics & valuation
Market cap$11.0B
P / E53.6×
P / S28.2×
P / B9.0×
P / FCF58.1×
Net margin52.6%
Return on equity16.8%
FCF margin48.5%
Return on capital13.1%
Graham number -76.2%$79.16
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($79.16); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 41.5% | 22.6% | -216.2% | — | — | — | — | — | — | — |
| Net margin | 52.6% | 30.7% | 21.6% | — | — | — | — | — | — | — |
| FCF margin | 48.5% | 41.0% | -198.4% | — | — | — | — | — | — | — |
| Return on assets | 15.4% | 8.4% | 1.3% | -25.1% | -11.1% | -10.3% | -9.1% | -9.4% | -15.8% | -52.7% |
| Return on equity | 16.8% | 9.4% | 1.4% | -26.8% | -11.7% | -11.0% | -9.4% | -9.6% | -16.0% | -397.9% |
| Current ratio | 9.95 | 7.28 | 17.76 | 13.30 | 17.18 | 17.80 | 58.88 | 43.39 | 77.99 | 50.44 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.